tiprankstipranks
Trending News
More News >
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
Advertisement

Sensei Biotherapeutics (SNSE) Stock Statistics & Valuation Metrics

Compare
216 Followers

Total Valuation

Sensei Biotherapeutics has a market cap or net worth of $10.07M. The enterprise value is -$21.20M.
Market Cap$10.07M
Enterprise Value-$21.20M

Share Statistics

Sensei Biotherapeutics has 1,261,290 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,261,290
Owned by Insiders31.23%
Owned by Institutions3.38%

Financial Efficiency

Sensei Biotherapeutics’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -77.23%.
Return on Equity (ROE)-0.79
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-77.23%
Return on Capital Employed (ROCE)-0.82
Revenue Per Employee0.00
Profits Per Employee-2.15M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Sensei Biotherapeutics is ―. Sensei Biotherapeutics’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value6.41
Price to FCF
Price to Operating Cash Flow-392.11
PEG Ratio

Income Statement

In the last 12 months, Sensei Biotherapeutics had revenue of 0.00 and earned -30.16M in profits. Earnings per share was -1.20.
Revenue0.00
Gross Profit-551.00K
Operating Income-32.61M
Pretax Income-30.16M
Net Income-30.16M
EBITDA-29.52M
Earnings Per Share (EPS)-1.20

Cash Flow

In the last 12 months, operating cash flow was -24.27M and capital expenditures -16.00K, giving a free cash flow of -24.28M billion.
Operating Cash Flow-24.27M
Free Cash Flow-24.28M
Free Cash Flow per Share-19.25

Dividends & Yields

Sensei Biotherapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.72
52-Week Price Change-36.50%
50-Day Moving Average7.90
200-Day Moving Average8.58
Relative Strength Index (RSI)47.13
Average Volume (3m)26.15K

Important Dates

Sensei Biotherapeutics upcoming earnings date is Nov 11, 2025, Before Open (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date

Financial Position

Sensei Biotherapeutics as a current ratio of 7.70, with Debt / Equity ratio of 9.37%
Current Ratio7.70
Quick Ratio7.70
Debt to Market Cap<0.01
Net Debt to EBITDA0.21
Interest Coverage Ratio-362.38

Taxes

In the past 12 months, Sensei Biotherapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Sensei Biotherapeutics EV to EBITDA ratio is -8.13, with an EV/FCF ratio of -9.67.
EV to Sales0.00
EV to EBITDA-8.13
EV to Free Cash Flow-9.67
EV to Operating Cash Flow-9.73

Balance Sheet

Sensei Biotherapeutics has $28.63M in cash and marketable securities with $2.56M in debt, giving a net cash position of -$26.07M billion.
Cash & Marketable Securities$28.63M
Total Debt$2.56M
Net Cash-$26.07M
Net Cash Per Share-$20.67
Tangible Book Value Per Share$1.53

Margins

Gross margin is 18.75%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin18.75%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Sensei Biotherapeutics is $32.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$32.50
Price Target Upside330.46% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast3.99%

Scores

Smart Score5
AI Score40
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis